Epigenetics in liver disease: from biology to therapeutics.
Epigenetics in liver disease: from biology to therapeutics.
复制标题
DOI:
10.1136/gutjnl-2015-311292
复制
发表时间:
2016-11
期刊:
影响因子:
24.5
通讯作者:
Mann DA
中科院分区:
文献类型:
--
作者:
Hardy T;Mann DA
Knowledge of the fundamental epigenetic mechanisms governing gene expression and cellular phenotype are sufficiently advanced that novel insights into the epigenetic control of chronic liver disease are now emerging. Hepatologists are in the process of shedding light on the roles played by DNA methylation, histone/chromatin modifications and non-coding RNAs in specific liver pathologies. Alongside these discoveries are advances in the technologies for the detection and quantification of epigenetic biomarkers, either directly from patient tissue or from body fluids. The premise for this review is to survey the recent advances in the field of liver epigenetics and to explore their potential for translation by industry and clinical hepatologists for the design of novel therapeutics and diagnostic/prognostic biomarkers. In particular, we present findings in the context of hepatocellular carcinoma, fibrosis and non-alcoholic fatty liver disease, where there is urgent unmet need for new clinical interventions and biomarkers.
登录
查看更多内容
影响因子:
64.5
作者:
Carone BR;Fauquier L;Habib N;Shea JM;Hart CE;Li R;Bock C;Li C;Gu H;Zamore PD;Meissner A;Weng Z;Hofmann HA;Friedman N;Rando OJ
通讯作者:
Rando OJ
影响因子:
13.5
作者:
Chen, Li;Charrier, Alyssa;Zhou, Yu;Chen, Ruju;Yu, Bo;Agarwal, Kitty;Tsukamoto, Hidekazu;Lee, L. James;Paulaitis, Michael E.;Brigstock, David R.
通讯作者:
Brigstock, David R.
影响因子:
13.5
作者:
Chen, Yangchao;Lin, Marie C.;Kung, Hsiang-fu
通讯作者:
Kung, Hsiang-fu
影响因子:
12.6
作者:
Chachay, Veronique S.;Macdonald, Graeme A.;Hickman, Ingrid J.
通讯作者:
Hickman, Ingrid J.
影响因子:
29.4
作者:
Angulo P;Kleiner DE;Dam-Larsen S;Adams LA;Bjornsson ES;Charatcharoenwitthaya P;Mills PR;Keach JC;Lafferty HD;Stahler A;Haflidadottir S;Bendtsen F
通讯作者:
Bendtsen F